Innovative high-tech cancer treatment Denmark-Germany

19. Oct 2016
Unfortunately, there are more cancer patients in the future. Towards 2025, the researchers predict an increase in the number of Danes who receive a cancer diagnosis at 25-30 percent.

The primary reason for the increase in the number of cancer patients is that we live longer. 

In InnoCan we work to make cancer treatment better and more gentle for the patients through:

  • Faster implementation of new innovative solutions, which will make it more comfortable to be a cancer patient, such as the C3 unit.
  • A test center for innovative monitoring technology across national borders, which will function as a gateway for companies with innovative solutions for hospitals. Read more about the test center here. 
  • Development of more gentle methods of treatment – with fewer side effects but with the same effect, for five well-defined cancers. To read more about the clinical trials that will lead to the new methods of treatment, click on the tab Research.
  • Development of a common database for the major cancers. This includes in-depth analysis of registry data that will support the long-term improvement of the quality of treatment. Read more under the tab cancer registry.

Facts
Purpose: To improve, simplify and shorten cancer treament
Budget: 32 million kroners
Project management: Head doctor Niels Henrik Holländer, Zealand University Hospital, Næstved, Department of Clinical Oncology and the Palliative Units 
Timeframe: July 1st 2015 - December 31st 2018
Supported by: EU Interreg 5a

Partners

  • Region Zealand, Production, Research and Innovation
  • Odense University Hospital, Department of Oncology
  • University College Absalon
  • Design School Kolding
  • Cortrium
  • The Danish Cancer Society
  • Department of Radiation Oncology, University of Lübeck / University Medical Center Schleswig-Holstein Campus Lübeck
  • Department of Radiation Therapy / Radiation Oncology, University Medical Center Schleswig-Holstein Campus Kiel / University of Kiel
  • The Institute of Cancer Epidemiology, University of Lübeck, Cancer Registry Schleswig-Holstein

Read more under the tap Partner Descriptions.

Network partners